Variant report
Variant | nsv1009349 |
---|---|
Chromosome Location | chr2:56715861-56743753 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:56712446..56715805-chr2:56715913..56718977,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2113864 | chr2:56732604-56732605 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs558219961 | chr2:56732619-56732620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193204170 | chr2:56732621-56732622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138888375 | chr2:56732658-56732659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529379433 | chr2:56732675-56732676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10193624 | chr2:56732701-56732702 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs34349569 | chr2:56732721-56732722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6756460 | chr2:56732729-56732730 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs538106380 | chr2:56732741-56732742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558070332 | chr2:56732797-56732798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571595426 | chr2:56732805-56732806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558051081 | chr2:56732844-56732845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533770599 | chr2:56732871-56732872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149382409 | chr2:56732964-56732965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527534551 | chr2:56732967-56732968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10193747 | chr2:56732978-56732979 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs10490406 | chr2:56732979-56732980 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs555505876 | chr2:56733019-56733020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185458803 | chr2:56733025-56733026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544430404 | chr2:56733039-56733040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564435818 | chr2:56733045-56733046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144713197 | chr2:56733053-56733054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189449759 | chr2:56733108-56733109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560289195 | chr2:56733132-56733133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368933677 | chr2:56733142-56733143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148510101 | chr2:56733156-56733157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373610230 | chr2:56733171-56733172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567593554 | chr2:56733184-56733185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569410807 | chr2:56733188-56733189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537417660 | chr2:56733192-56733193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs180715697 | chr2:56733204-56733205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183688223 | chr2:56733228-56733229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571524855 | chr2:56733248-56733249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533846007 | chr2:56733267-56733268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142745563 | chr2:56733287-56733288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114252807 | chr2:56733322-56733323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536279516 | chr2:56733325-56733326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376926208 | chr2:56733336-56733337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555817510 | chr2:56733352-56733353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536534962 | chr2:56733354-56733355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556462996 | chr2:56733384-56733385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150704782 | chr2:56733385-56733386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559652807 | chr2:56742206-56742207 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190410975 | chr2:56742290-56742291 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs182936732 | chr2:56742366-56742367 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188663690 | chr2:56742381-56742382 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568166921 | chr2:56742429-56742430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530927039 | chr2:56742430-56742431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538201743 | chr2:56742471-56742472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550725283 | chr2:56742487-56742488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56732600-56733400 | Enhancers | H9 Cell Line | embryonic stem cell |
2 | chr2:56742200-56742400 | Bivalent Enhancer | Fetal Heart | heart |
3 | chr2:56742200-56742800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:56742200-56743400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr2:56742800-56743000 | Bivalent Enhancer | Fetal Heart | heart |
6 | chr2:56743400-56745800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |